ADBE vs UNH: Which Is the Better Buy?
Side-by-side comparison of Adobe Inc. and UnitedHealth Group Incorporated โ fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-22.
Adobe Inc. ยท Technology
$248.16
+45.0% upside to fair value
High Conviction
Grade B
VS
UnitedHealth Group Incorporated ยท Healthcare
$353.52
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
ADBE trades at a lower forward P/E
(14.1x).
These are model outputs โ not personalized investment advice.
See all research โ
Valuation & Fundamentals
| Metric |
ADBE |
UNH |
| Current Price |
$248.16 |
$353.52 |
| Fair Value Estimate |
$359.82 |
$512.60 |
| Upside to Fair Value |
+45.0%
|
+45.0%
|
| Market Cap |
$101.2B |
$320.9B |
| Forward P/E |
14.1x
|
26.7x
|
| EV / EBITDA |
โ
|
16.1x
|
| Price / Sales |
4.1x
|
0.7x
|
| Price / FCF |
9.8x
|
16.3x
|
| Revenue Growth YoY |
+3.3%
|
+2.0%
|
| Gross Margin |
89.1%
|
18.8%
|
| Operating Margin |
36.6%
|
4.2%
|
| Return on Equity |
62.3%
|
12.4%
|
| Dividend Yield |
โ |
0% |
| FCF Yield |
10.2%
|
6.13%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Adobe Inc. develops industry-leading creative software, digital experience platforms, and publishing tools, powering digital content creation and marketing for professionals worldwide. The business excels with high gross margins above 89%, a sticky subscription model driving recurring revenue over $17B ARR, and dominant moats in digital media, though it faces intensifying AI competition and slowiโฆ
UnitedHealth Group Incorporated operates as a leading healthcare company with two main platforms: UnitedHealthcare, providing health benefits coverage, and Optum, offering information and technology services. The company benefits from a durable competitive moat due to its scale, integrated platforms, and broad market reach serving over 170 million consumers. Despite strong revenue growth of 12% yโฆ
Accumulation Zones
| Metric |
ADBE |
UNH |
| Zone Low |
$269.87 |
$384.45 |
| Zone High |
$305.85 |
$435.71 |
| In Buy Zone? |
Yes
|
Yes
|